Latest News

View All

Business and Finance
Clinical Operations

At BIO, San Diego touts its genomics breadth

FEATURES

A Conversation with John Chiminski, Catalent

In April, Catalent, Inc., celebrated its 10th anniversary of its inception, having been spun out of Cardinal Health in 2007 and acquired by Blackstone Group, a private-equity firm. Later, in 2014, the company went public, traded on the NYSE. Both

New science energizes the cancer market

Oncology drugs have had a prominent position in the biopharma industry, as well as healthcare generally, because the stakes are so high: cancer is often fatal; in its many forms, it is a common health condition; and, in recent years,

Compliance Package of the Year goes to Merck’s Zepatier

The winners of the Healthcare Compliance Packaging Council’s annual Compliance Package of the Year are in: the first-place winner is Merck’s Zepatier hepatitis C treatment, featuring a medication package designed by WestRock. Other award winners: First Runner Up: Braeburn Pharmaceuticals’

Is your corporate board equipped to monitor incentive programs?

As other sectors reel from government investigations into incentive programs, a growing number of life sciences board members are asking whether they, too, could be missing critical risks related to their organizations’ incentive programs. The answer may be yes. At

How cloud-based IT systems address FDA validation requirements

The life sciences community has always been more conservative when it comes to the adoption of new technologies, and cloud-based systems are no exception. This cautious approach to shiny new technology objects is more than appropriate given the high stakes

2017 Product Security Report

Pharmaceutical Commerce has used the term ‘Year Zero’ in talking about 2017 and the deadlines for compliance with the US Drug Supply Chain Security Act, simply because the key next step—having a unique serial number on each package of product […]

WE RECOMMEND

Information Technology

QuintilesIMS and Veeva battle over customer master data

Business and Finance

Integrichain, PharmaMetrics pair up to broaden revenue tracking in pharma transactions